The Claim

Daily supplementation with 30 billion pasteurized Akkermansia muciniphila MucT cells for 3 months increases hepatic insulin sensitivity by 12% in adults with metabolic syndrome and prediabetes who have low baseline gut levels of Akkermansia, as measured by HOMA-S.

Source: Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome: impact of low baseline gut Akkermansia levels

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
84score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Cause and effect
1 study reviewed
In plain English

In adults with metabolic syndrome and prediabetes who have low levels of Akkermansia muciniphila in their gut, taking 30 billion pasteurized Akkermansia muciniphila MucT cells daily for three months results in a 12% increase in hepatic insulin sensitivity, as measured by HOMA-S.

See the scientific wording

Daily supplementation with 30 billion pasteurized Akkermansia muciniphila MucT cells for 3 months significantly improves hepatic insulin sensitivity by 12% in adults with metabolic syndrome and prediabetes who have low baseline gut levels of Akkermansia, as measured by HOMA-S, suggesting targeted metabolic benefit for individuals with low endogenous Akkermansia abundance.

Why this might work

Dead Akkermansia bacteria release two proteins that travel to the gut. One protein fixes leaks in the gut lining, stopping harmful bacterial toxins from entering the blood. The other protein triggers gut cells to release a hormone that tells the liver and pancreas to use insulin better. Together, this lowers fat in the belly and makes the liver more responsive to insulin.

Verified mechanismbased on 1 study

What the research says

1 study
  1. Study: Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome: impact of low baseline gut Akkermansia levels

    People with low levels of a gut bacterium called Akkermansia who took a daily supplement of it for three months saw their liver become better at responding to insulin, helping control blood sugar — but only if they started with low levels of the bacteria.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.